PSORIASIS-VULGARIS, FETAL GROWTH, AND GENOMIC IMPRINTING

被引:38
|
作者
TRAUPE, H
VANGURP, PJM
HAPPLE, R
BOEZEMAN, J
VANDEKERKHOF, PCM
机构
[1] CATHOLIC UNIV NIJMEGEN,DEPT HUMAN GENET,NIJMEGEN,NETHERLANDS
[2] CATHOLIC UNIV NIJMEGEN,DEPT DERMATOL,NIJMEGEN,NETHERLANDS
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 1992年 / 42卷 / 05期
关键词
BIRTH WEIGHT; POLYGENIC INHERITANCE; EPIGENETIC MODIFICATION; DISEASE ACTIVITY;
D O I
10.1002/ajmg.1320420504
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We report on 2 independent lines of evidence suggesting genomic imprinting of a major gene for psoriasis vulgaris. First, the birth weight of children from psoriatics is influenced by the sex of the psoriatic parent. Children from fathers with psoriasis are considerably (270 g) heavier than children from mothers with psoriasis (P < 0.004). Second, the disease manifestation (penetrance) depends in part on the sex of the psoriatic parent. Offspring from fathers with psoriasis and male "gene carriers" are significantly (P < 0.015 and P < 0.007) more often affected than offspring from mothers with psoriasis and female "gene carriers." Of 91 grandchildren with psoriasis 59 (65%) have an affected grandfather and 32 (35%) a psoriatic grandmother. This deviation from the expected distribution is significant (P < 0.04). Genomic imprinting is considered a special case of epigenetic modification. We propose that epigenetic modifications of a major predisposing gene in somatic tissues could cause differences in disease activity of psoriasis and could account for the often unpredictable clinical course the disease takes.
引用
收藏
页码:649 / 654
页数:6
相关论文
共 50 条
  • [1] PSORIASIS-VULGARIS - 2 LINES OF EVIDENCE FOR GENOMIC IMPRINTING
    TRAUPE, H
    VANGURP, PJM
    VANDEKERKHOF, PCM
    BOEZEMAN, J
    HAPPLE, R
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 485 - 485
  • [2] PSORIASIS-VULGARIS
    MILBRADT, R
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1972, 97 (23) : 926 - &
  • [3] DIET IN PSORIASIS-VULGARIS
    BRAUNFALCO, O
    HAUTARZT, 1975, 26 (06): : 340 - 341
  • [4] RETROVIRUSES AND PSORIASIS-VULGARIS
    KRUGER, A
    ZEITSCHRIFT FUR HAUTKRANKHEITEN H&G, 1986, 61 (22): : 1585 - 1588
  • [5] PSORIASIS-VULGARIS AND HIV
    RUZICKA, T
    FROSCHL, M
    HOHENLEUTNER, U
    HOLZMANN, H
    HAUTARZT, 1988, 39 (09): : 617 - 617
  • [6] ALLOPHLOGISTY IN PSORIASIS-VULGARIS
    RASSNER, G
    HAUTARZT, 1972, 23 (10): : 445 - +
  • [7] HLA SYSTEM IN PSORIASIS-VULGARIS
    GSCHNAIT, F
    MAYR, WR
    BRENNER, W
    DERMATOLOGISCHE MONATSSCHRIFT, 1979, 165 (05): : 375 - 375
  • [8] PSYCHODYNAMIC ASPECTS OF PSORIASIS-VULGARIS
    VOGEL, PG
    ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE, 1976, 22 (02): : 177 - 189
  • [9] DARIERS DISEASE AND PSORIASIS-VULGARIS
    PREMALATHA, S
    YESUDIAN, P
    JAYAKUMAR, S
    THAMBIAH, AS
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1981, 20 (01) : 52 - 53
  • [10] TOPICAL PODOPHYLLOTOXIN IN PSORIASIS-VULGARIS
    WANTKE, F
    FLEISCHL, G
    GOTZ, M
    JARISCH, R
    DERMATOLOGY, 1993, 186 (01) : 79 - 79